Comparative proteomic profiling of MCF-7 breast cancer cells treated with doxorubicin.
Doxorubicin, an anthracycline antitumor drug, is widely used in the treatment of human breast cancer. While numerous studies have shown that doxorubicin is able to cause apoptosis, differentiation and growth arrest in cells, little is known about the associated effects doxorubicin has on the express...
Saved in:
Main Author: | Chan, Michelle Ching Ee. |
---|---|
Other Authors: | Chen Wei Ning, William |
Format: | Final Year Project |
Language: | English |
Published: |
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/16388 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
LC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cells
by: Bahareh Haji Rasouliha
Published: (2011) -
Protein profile in breast cancer patients undergoing doxorubicin treatment : an iTRAQ-coupled LC-MS/MS approach
by: Cheah, Chee Liang.
Published: (2009) -
Comparative LC-MS analysis of proteomics profile in cells incubated with S- or R-Ibuprofen and its inhibitory effect on angiogenesis induced by HBV replication
by: Zhang, Jianhua
Published: (2012) -
Diagnosis of breast cancer using skin surface electropotentials
by: Hee, Lily Li Li.
Published: (2010) -
Proteome-wide profiling of the MCF10AT breast cancer progression model
by: Choong, L.Y., et al.
Published: (2014)